COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,159 Articles (22,703 medRxiv, 8,456 bioRxiv)

Most recent first Previous |  Page 695: Articles 6941-6950  | Next

Extreme differences in SARS-CoV-2 Omicron viral loads among specimen types drives poor performance of nasal rapid antigen tests for detecting presumably pre-infectious and infectious individuals, predicting improved performance of combination specimen antigen tests
Viloria Winnett, A., Akana, R., Shelby, N., Davich, H., Caldera, S., Yamada, T., Reyna, J. R. B., Romano, A. E., Carter, A. M., Kim, M. K., Thomson, M., Tognazzini, C., Feaster, M., Goh, Y.-Y., Chew, Y. C., Ismagilov, R. F.
10.1101/2022.07.13.22277513 — Posted: 2022-07-15
Fully Quantitative Measurements of the Antibody Levels for SARS-CoV-2 Infections and Vaccinations calibrated against the NISTmAb Standard IgG Antibody
James-Pemberton, P. H., Helliwell, M. W., Olkhov, R. V., Kohli, S., Westlake, A. C., Farrar, B. M., Shaw, A.
10.1101/2022.07.12.22277533 — Posted: 2022-07-15
Bubble-PAPR: Phase I clinical evaluation of an in-house developed prototype powered air-purifying respirator for use by healthcare workers
McGrath, B. A., Shelton, C. L., Gardner, A., Coleman, R., Lynch, J., Alexander, P. G., Cooper, G.
10.1101/2022.07.14.22277643 — Posted: 2022-07-15
BA.4/BA.5 early surge report Austria
Gamisch, A., Mustafa, M. E.
10.1101/2022.07.12.22277534 — Posted: 2022-07-15
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses
Branche, A. R., Rouphael, N. G., Diemert, D. D., Falsey, A. R., Losada, C., Baden, L. R., Frey, S. E., Whitaker, J. A., Little, S. J., Anderson, E. J., Walter, E. B., Novak, R. M., Rupp, R., Jackson, L. A., Babu, T. M., Kottkamp, A. C., Luetkemeyer, A. F., Immergluck, L. C., Presti, R. M., Backer, M., Winokur, P. L., Mahgoub, S. M., Goepfert, P. A., Fusco, D. N., Malkin, E., Bethony, J. M., Walsh, E. E., Graciaa, D. S., Samaha, H., Sherman, A. C., Walsh, S. R., Abate, g., Oikonomopoulou, Z., El Sahly, H. M., Martin, T. C., Rostad, C. A., Smith, M., Ladner, B. G., Porterfield, L., Dunstan, M., Wald, A., Davis, T., Atmar, R. L., Mulligan, M. J., Lyke, K. E., Posavad, C. M., Meagher, M. A., Stephens, D. S., Neuzil, K. M., Abebe, K., Hill, H., Albert, J., Lewis, T. C., Giebeig, L. A., Eaton, A., Netzl, A., Wilks, S. H., Tureli, S., Mahkene, M., Crandon, S., Lee, M., Nayak, S. U., Montefiori, D. C., Matkowski, M., Smith, D. J., Roberts, P. C., Beigel, J. H.
10.1101/2022.07.12.22277336 — Posted: 2022-07-15
An Evaluation of the Safety and Immunogenicity of MVC-COV1901: Results of an interim analysis of a phase III, parallel group, randomized, double-blind, active-controlled study
Barrios, L., Garcia, L. A., Torales, J., Lin, M.-Y., Estrada, J. A. G., Estephan, L., Cheng, H.-Y., Chen, C., Lien, C. E.
10.1101/2022.07.14.22277617 — Posted: 2022-07-15
Tracing the international arrivals of SARS-CoV-2 Omicron variants after Aotearoa New Zealand reopened its border
Douglas, J., Winter, D., Ren, X., McNeill, A., Bunce, M., French, N., Hadfield, J., de Ligt, J., Welch, D., Geoghegan, J. L.
10.1101/2022.07.12.22277518 — Posted: 2022-07-15
Effect of Vitamin D3 supplementation vs. dietary-hygienic measures on SARS-COV-2 infection rates in hospital workers with 25-hydroxyvitamin D3 levels >20 ng/mL
Romero-Ibarguengoitia, M. E., Gutierrez-Gonzalez, D., Cantu-Lopez, C., Sanz-Sanchez, M. A., Gonzalez-Cantu, A.
10.1101/2022.07.12.22277450 — Posted: 2022-07-15
SARS-CoV-2 causes brain inflammation via impaired neuro-immune interactions
Oka, N., Shimada, K., Ishii, A., Kobayashi, N., Kondo, K.
10.1101/2022.07.13.499991 — Posted: 2022-07-15
Hospital admissions and mortality for acute exacerbations of COPD during the COVID-19 pandemic: a nationwide study in France
Poucineau, J., Delory, T., Lapidus, N., Hejblum, G., Chouaid, C., Le Coeur, S., Khlat, M.
10.1101/2022.07.11.22277259 — Posted: 2022-07-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).